MALDI Glycan Analytical Validation (Stanford)
BRD ID: 3384
Tier: SOP
Source: CIMAC-CIDC Network
Number of times downloaded: 172
Description
This assay analytical validation and performance report describes the methods used to validate a matrix-assisted laser desorption/ionization (MALDI) imaging mass spectrometry (IMS) method for the analysis of N-glycans in formalin-fixed, paraffin-embedded tissue. MALDI-IMS data from four kidney specimens were presented in conjunction with images of corresponding H&E stained FFPE sections in support of the accuracy, precision, robustness, and reproducibility of the assay. The report is used by the Cancer Immune Monitoring and Analysis Center (CIMAC) at Stanford University. It is a product of the Cancer Immune Monitoring and Analysis Center Cancer Immunologic Data Center Network (CIMAC-CIDC Network); https://dctd.cancer.gov/research/networks/precision-medicine-oncology/cimac-cidc).
Biospecimens
TissueKidney
Diagnoses
Other diagnoses
NeoplasticCarcinoma
General
Normal
Topics
Platform-specific Methodology